--2025/Q1-- / 2.711M--
--2024/Q4-- / 6.228M--
--2024/Q34.346M / 11.849M--
--2024/Q22.766M / 1.817M--
May 7, 20242024/Q12.398M / 1.929M--
MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
ACRS Aclaris Therapeutics
- 2.720
- -0.050-1.81%
Close Dec 20 16:00 ET
- 3.000
- +0.280+10.29%
Post 20:01 ET
291.00MMarket Cap-5.23P/E (TTM)
2.900High2.710Low1.16MVolume2.740Open2.770Pre Close3.19MTurnover1.56%Turnover RatioLossP/E (Static)106.99MShares5.17052wk High2.24P/B202.58MFloat Cap0.85652wk Low--Dividend TTM74.48MShs Float33.880Historical High--Div YieldTTM6.86%Amplitude0.590Historical Low2.754Avg Price1Lot Size
Aclaris Therapeutics Key Stats
Aclaris Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Aclaris Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data